Ads
related to: side effects of dupixent- FAQs
Find Answers To Your Questions
& Understand Treatment Now
- Pricing And Insurance
Check Copay Eligibility
Learn About Payment Options
- Injection Support Center
Get Help With Taking DUPIXENT®
View Injection Resources Now
- Patient Support
Access DUPIXENT MyWay®
Get Patient Journey Support Today
- FAQs
Search results
The Next Humira? Insmed Catapults 119% On Its 'Very Attractive' Opportunity In Lung Disease.
Investor's Business Daily· 2 hours agoInsmed stock catapulted Tuesday after the biotech company's experimental lung disease treatment...
UK Drug Regulator Warns Of Severe Eye Reactions Associated With Sanofi/Regeneron's Dupixent
Benzinga via Yahoo Finance· 1 year agoThe UK's Medicines and Healthcare Regulatory Agency (MHRA) warned of some new and severe eye-related...
Is Sanofi on the Verge of Another Blockbuster?
Motley Fool· 2 years agoThe U.S. Food and Drug Administration (FDA) recently announced that it had accepted Sanofi (NASDAQ: SNY) and Regeneron's (NASDAQ: REGN) supplemental...
Regeneron, Sanofi Plot A Major Expansion That Could Add $4 Billion In Future Sales
Investor's Business Daily· 6 months agoRegeneron Pharmaceuticals and Sanofi said Monday their blockbuster drug, Dupixent, significantly...
Regeneron Breaks Out On Home Run In 'Smoker's Lung' As Sanofi Soars
Investor's Business Daily· 1 year agoSanofi and Regeneron Pharmaceuticals' asthma drug Dupixent succeeded in a final-phase study of...
Regeneron, Sanofi to seek new Dupixent approval in US after COPD success
BioPharma Dive via Yahoo Finance· 6 months agoResults from the second of two Phase 3 trials testing the blockbuster drug in the respiratory...
FDA Approves the First Oral Treatment for Eosinophilic Esophagitis
Verywell Health via Yahoo News· 3 months agoVerywell / Julie Bang Fact checked by Nick Blackmer Key Takeaways The FDA approved Takeda’s Eohilia,...
The Unexpectedly Good News That Helped Regeneron Retake Its 200-Day Line
Investor's Business Daily· 10 months agoRegeneron Pharmaceuticals predicted a faster-than-expected approval timeline for a high dose of its...
Insmed shares double as lung drug data convince Wall Street
BioPharma Dive via Yahoo Finance· 9 hours agoAfter reporting positive clinical trial results for its drug brensocatib, Insmed plans to later this...
UK regulator calls for review of reactions in eyes to Sanofi asthma drug
Reuters via Yahoo News· 1 year agoThe UK's Medicines and Healthcare products Regulatory Agency said most ocular reactions seen with...
Ads
related to: side effects of dupixent